These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

64 related items for PubMed ID: 5589840

  • 21. A comparison of the effects of some monoamine oxidase (MAO) inhibitors with 5-hydroxytryptophan (5-HTP) and dihydroxyphenylalanine (DOPA) on spinal synaptic activity.
    Anderson EG, Baker R, Banna N.
    Proc West Pharmacol Soc; 1966; 9():40-1. PubMed ID: 5958499
    [No Abstract] [Full Text] [Related]

  • 22. Influence of sympathetic stimulation on segmental vascular resistance before and after adrenergic neuronal blockade.
    Zimmerman BG.
    Arch Int Pharmacodyn Ther; 1966 Mar; 160(1):66-82. PubMed ID: 5960129
    [No Abstract] [Full Text] [Related]

  • 23. The effect of pargyline pretreatment on the enhancement of the exocytotic release of norepinephrine during nerve stimulation which is induced by a benzoquinolizine compound with reserpine-like properties.
    Langley AE, Weiner N.
    J Pharmacol Exp Ther; 1980 Jun; 213(3):534-8. PubMed ID: 6907314
    [Abstract] [Full Text] [Related]

  • 24. D-amphetamine-induced hydrogen peroxide production in skeletal muscle is modulated by monoamine oxidase inhibition.
    Duarte JA, Carvalho F, Fernandes E, Remião F, Bastos ML, Magalhães J, Appell HJ.
    Int J Sports Med; 2004 Aug; 25(6):446-9. PubMed ID: 15346233
    [Abstract] [Full Text] [Related]

  • 25. Effect of monoamine oxidase (MAO) inhibition upon the N, P and LN potentials of the rabbit superior cervical ganglia.
    Henderson G, Blakeley AG.
    Br J Pharmacol; 1971 Oct; 43(2):436P. PubMed ID: 4333807
    [No Abstract] [Full Text] [Related]

  • 26. Effects of reboxetine on sympathetic neuroeffector transmission in rabbit carotid artery.
    Rasmussen LE, Nedergaard OA.
    J Pharmacol Exp Ther; 2003 Sep; 306(3):995-1002. PubMed ID: 12754319
    [Abstract] [Full Text] [Related]

  • 27. Effect of some monoamine oxidase inhibitors on reflex pressor and nictitating membrane responses.
    Bose D, Bhagwat AW, Agarwal SL.
    Indian J Med Res; 1967 Aug; 55(8):884-8. PubMed ID: 5598205
    [No Abstract] [Full Text] [Related]

  • 28. Trans-synaptic induction of dopamine (3,4-dihydroxyphenethylamine) -hydroxylase in adrenergic tissues of the rat.
    Molinoff PB, Brimijoin S, Axelrod J.
    Biochem J; 1971 Jul; 123(4):32P-33P. PubMed ID: 4399553
    [No Abstract] [Full Text] [Related]

  • 29. The mechanism underlying potentiation of the pressor action of noradrenaline by some drugs which depress sympathetic tone.
    Karim SM.
    J Pharm Pharmacol; 1965 May; 17(5):302-8. PubMed ID: 4378672
    [No Abstract] [Full Text] [Related]

  • 30. Phenylisopropylmethylpropinylamine (E-250), a new spectrum psychic energizer.
    Knoll J, Ecseri Z, Kelemen K, Nievel J, Knoll B.
    Arch Int Pharmacodyn Ther; 1965 May; 155(1):154-64. PubMed ID: 4378644
    [No Abstract] [Full Text] [Related]

  • 31. Paradoxical elevation of sympathetic activity during catecholamine infusion in rats.
    Johnson MD, Smith PG, Mills E, Schanberg SM.
    J Pharmacol Exp Ther; 1983 Oct; 227(1):254-9. PubMed ID: 6312020
    [Abstract] [Full Text] [Related]

  • 32. [Effect of reserpine, aldomet and ornid on the transmission of excitability from the sympathetic nerves on the vessles].
    Kisin IE.
    Farmakol Toksikol; 1966 Oct; 29(6):652-7. PubMed ID: 6000359
    [No Abstract] [Full Text] [Related]

  • 33. Interaction of phenoxybenzamine with guanethidine and bretylium at the sympathetic nerve endings of the isolated perfused spleen of the cat.
    Thoenen H, Huerlimann A, Haefely W.
    J Pharmacol Exp Ther; 1966 Feb; 151(2):189-95. PubMed ID: 5932597
    [No Abstract] [Full Text] [Related]

  • 34. The influence of sympathetic nervous activity on cardiac catecholamine levels.
    Bhagat B.
    J Pharmacol Exp Ther; 1967 Jul; 157(1):74-80. PubMed ID: 4382101
    [No Abstract] [Full Text] [Related]

  • 35. Interactions of bretylium and acetylcholine at sympathetic nerve endings.
    Fischer JE, Weise VK, Kopin IJ.
    J Pharmacol Exp Ther; 1966 Sep; 153(3):523-9. PubMed ID: 5921529
    [No Abstract] [Full Text] [Related]

  • 36. The monoamine oxidase inhibitor phenelzine enhances the discriminative stimulus effect of nicotine in rats.
    Wooters TE, Bardo MT.
    Behav Pharmacol; 2007 Nov; 18(7):601-8. PubMed ID: 17912044
    [Abstract] [Full Text] [Related]

  • 37. [BRETYLIUM-LIKE ACTION OF A MONOAMINE OXIDASE INHIBITOR].
    GESSA GL.
    Boll Soc Ital Biol Sper; 1963 Sep 15; 39():984-6. PubMed ID: 14091357
    [No Abstract] [Full Text] [Related]

  • 38. Neuroprotection by monoamine oxidase B inhibitors: a therapeutic strategy for Parkinson's disease?
    Tabakman R, Lecht S, Lazarovici P.
    Bioessays; 2004 Jan 15; 26(1):80-90. PubMed ID: 14696044
    [Abstract] [Full Text] [Related]

  • 39. Sympathetic cardiac stimulation in Bufo marinus under MS-222 anesthesia.
    Smith DG.
    Am J Physiol; 1974 Feb 15; 226(2):367-70. PubMed ID: 4359514
    [No Abstract] [Full Text] [Related]

  • 40. Electron microscopic evidence that bretylium and pargyline delay adrenergic nerve degeneration after sympathectomy of the pineal gland.
    Sanz NR, Gomez-Dumm GL, Perec CJ, Stefano FJ.
    Naunyn Schmiedebergs Arch Pharmacol; 1982 May 15; 319(2):136-9. PubMed ID: 7110375
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.